Company news

InnoCare Pharma Ltd. news in 2024

InnoCare Pharma Ltd.'s news releases, calls and decks from 2024, newest first.

View company

Indicative Announcement on the Postponement of By-election for Independent Non-executive Director

December 24, 2024

Announcement on the First Granting of Restricted Stocks to Incentive Objects

December 17, 2024

Notice on the Review Opinions and Remarks on Publicity of Lis of Incentive Recipients List for the Initial Grant of the 2024 SSE STAR Market Restricted Stock Incentive Plan

December 9, 2024

Notice on Convening the 1st Extraordinary General Meeting (Shareholders' Special Meeting) in 2024

November 28, 2024

Summary Announcement on the 2024 STAR Market Restricted Stock Incentive Plan (Draft)

November 26, 2024

The Q3 2024 Report

November 11, 2024

Announcement on Convening the Q3 2024 Performance Briefing

November 4, 2024

Announcement on Voluntary Disclosure of Phase II Clinical Trial Result of ICP-488

October 9, 2024

Announcement on the Resignation of Non-executive Directors and Independent Non-executive Directors and the Change of Members of Special Committees of the Board of Directors

September 25, 2024

Announcement on Change of Sponsor Representative for Continuous Supervision

September 20, 2024

Announcement on Listing and Circulation of Initial Public Offering of Strategic Placement Restricted Shares

September 10, 2024

Announcement on Voluntary Disclosure of Clinical Trial Progress of Aobrutinib

September 8, 2024

Semi-annual Report in 2024

August 20, 2024

Announcement on Convening the 2024 Semi-Annual Performance Briefing

August 13, 2024

Announcement on Voluntary Disclosure of Completing the 1st Administration of ICP-332 in Patients in the United States

July 24, 2024

Indicative Announcement on Change in Equity of Shareholder with Over 5% Shares

July 19, 2024

Announcement on the "Corporate Value and Return Enhancement" Action Plan 2024

July 17, 2024

Decks in 2024